论文信息 - Open label, multi-centre phase II study of raltitrexed ('Tomudex') in patients with inoperable squamous-cell carcinoma of head and neck. - 字舞流文

Open label, multi-centre phase II study of raltitrexed ('Tomudex') in patients with inoperable squamous-cell carcinoma of head and neck.

S. Clarke | J. Zalcberg | D. Rischin | M. Green | I. Olver | D. Dalley | P. Mitchell | P. Mitchell | S. Clarke | Y. E. Davidson | M. D. Green